Form 4: Ironwood Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Andrew Davis, SVP and Chief Business Officer of Ironwood Pharmaceuticals, sold 22,725 shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 20, 2024, Andrew Davis, SVP, Chief Business Officer of Ironwood Pharmaceuticals, sold 22,725 shares of Class A Common Stock.
• The sale was executed at a price of $6.45 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units and performance-based restricted stock units.
• Following the transaction, Davis directly owns 288,031 shares of Ironwood Pharmaceuticals' Class A Common Stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transaction is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.

Management Comments

• The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax planning. The sale itself doesn't necessarily indicate a negative outlook for the company.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small number of shares sold.

Key Dates